Sunshine Biopharma (SBFM) Operating Leases (2019 - 2026)
Sunshine Biopharma (SBFM) posted Operating Leases of $475,820 for Q2 2026, down 32.7% from $706,530 a year earlier and down 11.2% from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Sunshine Biopharma's Operating Leases came in at $596,785, down 19.9% from FY2024.
- Annual Operating Leases shows a three-year compound annual growth rate of -2.4% (FY2022 to FY2025).
- In prior years, Sunshine Biopharma's Operating Leases was $744,724 in FY2024 (+38.2%), $539,035 in FY2023 (-16.1%) and $642,232 in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Operating Leases since Q3 2024.
- On a year-over-year basis, Operating Leases has declined in each of the last three quarters, with growth averaging 10.2% over the last eight quarters.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q2 2025, with growth of 52.6%; the weakest was Q2 2026, with a decline of 32.7%.
- According to Business Quant data, Operating Leases for the three prior quarters was $535,614 (Q1 2026), $596,785 (Q4 2025) and $636,708 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Sunshine Biopharma | 1.12 Mn | -37.97 Mn | 2.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 475,820.00 |
| Mar 31, 2026 | 535,614.00 |
| Dec 31, 2025 | 596,785.00 |
| Sep 30, 2025 | 636,708.00 |
| Jun 30, 2025 | 706,530.00 |
| Mar 31, 2025 | 722,199.00 |
| Dec 31, 2024 | 744,724.00 |
| Sep 30, 2024 | 440,298.00 |
| Jun 30, 2024 | 462,906.00 |
| Mar 31, 2024 | 496,968.00 |
| Dec 31, 2023 | 539,035.00 |
| Sep 30, 2023 | 555,687.00 |
| Jun 30, 2023 | 596,850.00 |
| Mar 31, 2023 | 613,136.00 |
| Dec 31, 2022 | 642,232.00 |
| Mar 31, 2019 | 49,148.00 |
API Access
Sunshine Biopharma Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();